Posts

Matchpoint Therapeutics raises $150M to advance autoimmune drug toward clinic

on

Glioblastoma vaccine misses trial goal overall, with a signal in younger patients

on

TCGX raises $600 million for Asia-focused biotech fund

on

Dutch court blocks subcutaneous Keytruda in eight European markets

on

Icotyde: strong two-year trial results

on

Cerevance reports Phase 3 win for experimental Parkinson’s drug

on

GLP-1 boom pushes drugmakers to market to consumers

on

Five of the biggest venture capital raises of Q3 2026

on

Forbion raises record €2.3 billion with Eli Lilly among its backers

on

ArriVent lung cancer drug misses Phase 3 target

on

AstraZeneca opens major R&D centre in Cambridge, Massachusetts

on

Caribou halts CAR-T programs and weighs strategic options after funding shortfall

on

PulseSight reports preliminary PST-611 signals in a six-person Phase I study

on